Advertisement

GI & Endoscopy

Spectrum Pharmaceuticals has received approval from the U.S. Food and Drug Administration for the use of FUSILEV (levoleucovorin) in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer, according to a company news release.

Researchers at Tufts University's School of Engineering have developed a device that could potentially reduce patient discomfort during routine colonoscopies while also ensuring the accuracy of the exam, according to a university news release.

Advertisement
Advertisement